background

Contract Development and Manufacturing Organisation (CDMO)

Contract Development and Manufacturing Organisation (CDMO)

Beyond manufacturing, Cipro Pharmaceuticals operates as a CDMO, offering end to end development solutions.

  • A dedicated R&D facility is integrated with the manufacturing site, enabling seamless transition from laboratory innovation to commercial production.
  • Expertise lies in the development of generic molecules tailored for international markets, ensuring cost effective and compliant formulations.
  • The R&D team focuses on formulation development, scale up, and technology transfer, providing clients with a complete pathway from concept to market.
  • This dual capability strengthens Cipro’s position as a strategic partner for pharmaceutical companies seeking both development and manufacturing excellence.